Kymera Therapeutics names ex-Sanofi executive to lead KT-621 program

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/19/2026

1. KLAR
2. KEYS
3. PANW
4. MRNA
5. HD
6. DVLT
7. LOW
8. MRK
9. PGR
10. EPM

Go back to Kymera Therapeutics names ex-Sanofi executive to lead KT-621 program
(NASDAQ: KYMR) Delayed: 124.61 +3.23 (2.66%)
Previous Close $121.38    52 Week High $ 
Open $124.63    52 Week Low $ 
Day High $125.23    P/E N/A 
Day Low $121.83    EPS $ 
Volume 369,648